News
Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would ...
Analysts have provided the following ratings for Akili (NASDAQ:AKLI) within the last quarter: In the last 3 months, 4 analysts have offered 12-month price targets for Akili. The company has an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results